Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

EVOK
Evoke Pharma, Inc.
stock NASDAQ

At Close
May 9, 2025 3:59:30 PM EDT
3.14USD-2.786%(-0.09)11,626
0.00Bid   0.00Ask   0.00Spread
Pre-market
Dec 31, 1969 7:00:00 PM EST
0.00USD-100.000%(-3.23)0
After-hours
May 6, 2025 4:45:30 PM EDT
3.00USD-9.091%(-0.30)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 4, 2022
08:30AM EST  Evoke Pharma to Participate in the H.C. Wainwright BIOCONNECT   GlobeNewswire Inc
Nov 10, 2021
06:27PM EST  Evoke Pharma Q3 EPS $(0.06) Beats $(0.07) Estimate, Sales $930.45K Beat $380.00K Estimate   Benzinga
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 3, 2021
08:30AM EDT  Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that the Company is scheduled to release its third quarter 2021 financial results on Wednesday, November 10, 2021, after the market closes.   GlobeNewswire Inc
Oct 20, 2021
08:50AM EDT  Evoke Pharma Announces Positive Findings From Market Research Study Conducted For GIMOTI Nasal Spray   RTTNews
08:32AM EDT  Evoke Pharma, EVERSANA Reports Findings From GIMOTI Market Research Study   Benzinga
08:30AM EDT  Health care practitionersperception of nasal route of administration similar to IV;92% intend to prescribeGIMOTI   GlobeNewswire Inc
Sep 30, 2021
11:19AM EDT  Looking Into Evoke Pharma's Return On Capital Employed   Benzinga
Sep 29, 2021
08:30AM EDT  Award for Spray Away Campaign seeking to drive patient and provider awareness for the novel nasal spray treatment of symptoms of Diabetic Gastroparesis   GlobeNewswire Inc
Sep 1, 2021
08:30AM EDT  Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that Dave Gonyer R.Ph., President and Chief Executive Officer, and Matt DOnofrio, Chief Business Officer, will participate virtually in the H.C. Wainwright 23rd Annual Global Investment Conference taking place from September 13 15, 2021.   GlobeNewswire Inc
Aug 12, 2021
05:02PM EDT  Evoke Pharma Q2 EPS $(0.07) Beats $(0.08) Estimate   Benzinga
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 2, 2021
08:30AM EDT  Evoke Pharma and EVERSANA Announce Support of The International   GlobeNewswire Inc
Jul 27, 2021
11:13AM EDT  The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts   Benzinga
Jul 14, 2021
08:30AM EDT  Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the start of additional marketing initiatives focusing on the launch of a patient and physician experience program for GIMOTI, the Companys nasal spray product for the relief of symptoms in acute and recurrent diabetic gastroparesis (DGP).   GlobeNewswire Inc
Jun 29, 2021
08:30AM EDT  Evoke Pharma, EVERSANA and The International Foundation for   GlobeNewswire Inc
Jun 15, 2021
08:46AM EDT  Evoke Pharma, EVERSANA Report Positive Findings From A Second Market Research Study On GIMOTI   RTTNews
08:41AM EDT  Evoke Pharma And EVERSANA Highlight Findings From Second GIMOTI Market Research Study   Benzinga
08:30AM EDT  Evoke Pharma and EVERSANA Announce Positive Findings from Second   GlobeNewswire Inc
Jun 8, 2021
08:37AM EDT  Evoke Pharma Reports FDA Orange Book Listing Of U.S. Patent For Gimoti   RTTNews
08:35AM EDT  Evoke Pharma Announces FDA Orange Book Listing Of US Patent For Gimoti   Benzinga
08:30AM EDT  Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for   GlobeNewswire Inc
Jun 2, 2021
08:38AM EDT  Evoke Pharma Announces Issuance Of U.S. Patent Covering Methods Of Use For Gimoti   Benzinga
08:30AM EDT  New patent expands intellectual property protection for nasal delivery of metoclopramide and is expected to be FDA Orange Book listed   GlobeNewswire Inc
May 27, 2021
08:30AM EDT  Evoke is committed to meeting patients online, where they search for answers   GlobeNewswire Inc
May 25, 2021
07:53AM EDT  The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal   Benzinga
May 14, 2021
08:35AM EDT  Evoke Pharma Adds Vickie Reed To Board   RTTNews
08:30AM EDT  Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the appointment of Vickie Reed to the Companys board of directors. After serving for more than eight years on the Companys board, Ann Rhoads has announced her retirement.   GlobeNewswire Inc
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 13, 2021
02:36PM EDT  Mid-Afternoon Market Update: Dow Jumps Over 500 Points; ContextLogic Shares Plunge   Benzinga
12:14PM EDT  Mid-Day Market Update: Crude Oil Down 3%; Flux Power Shares Rise After Q3 Results   Benzinga
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
May 12, 2021
04:40PM EDT  Evoke Pharma Q1 EPS $(0.08) Misses $(0.06) Estimate, Sales $90.00K Miss $830.00K Estimate   Benzinga
04:05PM EDT  Nearly 293% growth of product sales, 235% growth of prescriptions and 87% increase in new prescribers for Gimoti   GlobeNewswire Inc
04:22AM EDT  Earnings Scheduled For May 12, 2021   Benzinga
May 5, 2021
08:30AM EDT  Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that the Company is scheduled to release its first quarter 2021 financial results on Wednesday, May 12, 2021, after the market closes.   GlobeNewswire Inc
Apr 6, 2021
08:33AM EDT  Evoke Pharma Says Receives Notice Of Allowance From U.S. Patent, Trademark Office For Method Of Use Patent With Claims Covering Gimoti   Benzinga
08:30AM EDT  Evoke Pharma Receives Notice of Allowance from United States   GlobeNewswire Inc
Mar 30, 2021
08:30AM EDT  Evoke Pharma Announces a Fireside Chat with Key Opinion Leaders on   GlobeNewswire Inc
Mar 12, 2021
02:42PM EST  Mid-Afternoon Market Update: Dow Surges Over 200 Points; Prometheus Biosciences Shares Spike Higher   Benzinga
12:11PM EST  Mid-Day Market Update: Evoke Pharma Falls Following Q4 Earnings; NLS Pharmaceutics Shares Climb   Benzinga
10:13AM EST  Mid-Morning Market Update: Markets Mixed; Buckle Earnings Top Views   Benzinga
07:36AM EST  The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs   Benzinga
Mar 11, 2021
04:27PM EST  Evoke Pharma Q4 EPS $(0.09) Beats $(0.13) Estimate   Benzinga
04:05PM EST  Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter ended December 31, 2020 and recent corporate developments.   GlobeNewswire Inc
03:35AM EST  Earnings Scheduled For March 11, 2021   Benzinga
Mar 4, 2021
04:05PM EST  Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that the Company is scheduled to release its fourth quarter and full year 2020 financial results on Thursday, March 11, 2021, after the market closes.   GlobeNewswire Inc
Feb 9, 2021
10:15AM EST  Shares of Evoke Pharma, Inc. (EVOK) are up nearly 30% on Tuesday morning despite no stock-related news to drive the shares.   RTTNews
Jan 20, 2021
08:30AM EST  Evoke Pharma Announces Closing of Public Offering of Common Stock   GlobeNewswire Inc
Jan 14, 2021
10:08AM EST  Evoke Pharma shares were trading lower after the company priced its 5 million shares common stock offering at $2.50 per share.   Benzinga
07:57AM EST  The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates   Benzinga
06:36AM EST  Evoke Pharma Priced 5M Share Public Offering of Common Stock @$2.50/Share on Wednesday   Benzinga
Jan 13, 2021
08:03PM EST  Evoke Pharma Announces Pricing of Public Offering of Common Stock   GlobeNewswire Inc
04:03PM EST  Evoke Pharma Announced A Common Stock offering; No Terms Disclosed   Benzinga
04:02PM EST  Evoke Pharma Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
08:45AM EST  Evoke Pharma Reports Findings From GIMOTI Market Research Study   Benzinga
08:30AM EST  Evoke Pharma, Inc. (Evoke or the Company) (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced positive findings from the first market research for GIMOTI following its launch during the fourth quarter of 2020.   GlobeNewswire Inc
Nov 10, 2020
08:32AM EST  Evoke Pharma Q3 EPS $(0.08) Down From $(0.07) YoY   Benzinga
08:30AM EST  Evoke Pharma Reports Third Quarter 2020 Financial Results   GlobeNewswire Inc
Nov 4, 2020
05:56AM EST  What's moving these stocks in the pre-market hours today?   RTTNews
Oct 26, 2020
08:31AM EDT  Evoke, EVERSANA Announce Commercial Launch of Gimoti   Benzinga
08:30AM EDT  Evoke and EVERSANA Announce Commercial Launch of   GlobeNewswire Inc
Sep 9, 2020
08:30AM EDT  Evoke Pharma to Participate in the H.C. Wainwright 22nd Annual   GlobeNewswire Inc
Aug 25, 2020
08:30AM EDT  Evoke Pharma and EVERSANA Announce the Appointment of Christopher   GlobeNewswire Inc
Aug 6, 2020
10:04AM EDT  Evoke Pharma Q2 EPS $(0.28) Down From $(0.09) YoY   Benzinga
Jul 15, 2020
08:40AM EDT  Evoke Pharma Begins Commercial Manufacturing Of Gimoti Nasal Spray   RTTNews
08:30AM EDT  Evoke Pharma Initiates Commercial Manufacturing of Gimoti   Benzinga
08:30AM EDT  Evoke Pharma Initiates Commercial Manufacturing of   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC